Corbion Yönetim
Yönetim kriter kontrolleri 3/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Olivier Rigaud
İcra Kurulu Başkanı
€1.5m
Toplam tazminat
| CEO maaş yüzdesi | 49.10% |
| CEO görev süresi | 6.8yrs |
| CEO sahipliği | n/a |
| Yönetim ortalama görev süresi | 2.1yrs |
| Yönetim Kurulu ortalama görev süresi | 1.1yrs |
Son yönetim güncellemeleri
Analiz Makalesi • May 07
Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely
Key Insights Corbion's Annual General Meeting to take place on 14th of May Salary of €725.0k is part of CEO Olivier...Analiz Makalesi • May 08
Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely
Key Insights Corbion will host its Annual General Meeting on 15th of May Salary of €713.0k is part of CEO Olivier...Recent updates
Anlatı Güncellemesi • Jun 01
CRBN: Special Dividend And Steady Guidance Will Support Future Re Rating
Analysts kept Corbion's fair value target steady at €28.00, citing modest adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions after the recent downgrade highlighted by Barclays. What's in the News Shareholders approved a total dividend of €1.00 per share for the 2025 financial year, including a special dividend of €0.36 per share, at the Annual General Shareholders Meeting on 13 May 2026.Anlatı Güncellemesi • May 09
CRBN: Special Dividend And Higher Future P E Could Support Re Rating
Analysts have reduced their fair value estimate for Corbion from €30.00 to €28.00, citing updated assumptions for revenue growth, profit margins and future P/E following recent research, including the Barclays downgrade. Analyst Commentary Recent research has led to a lower fair value estimate for Corbion, but bullish analysts still highlight several supports for the stock, focusing on how current assumptions around revenue, margins and P/E could play out over time.
Anlatı Güncellemesi • Apr 22
CRBN: Special Dividend And Execution On Margins Will Support Upside Potential
The updated analyst price target for Corbion has shifted slightly to about €24.03 from €24.17, as analysts adjust their assumptions around discount rate, revenue growth, profit margin and future P/E in light of recent research, including the Barclays downgrade. Analyst Commentary Bullish Takeaways Bullish analysts see the updated price target around €24.03 as still leaving some room for upside if Corbion executes well on its revenue and margin assumptions embedded in the models.
Anlatı Güncellemesi • Apr 08
CRBN: Raised Fair Value And Barclays Downgrade Will Shape Risk Balance
Analysts now set Corbion's fair value at €19.60, up from €18.60. This reflects updated assumptions on growth, margins and P/E multiples, even as some recent research, including a downgrade at Barclays, highlights ongoing risks.Anlatı Güncellemesi • Mar 24
CRBN: Higher Margins And Special Dividend Will Support Future Re Rating
Analysts have maintained their price target for Corbion at €30.00, citing updated assumptions around the discount rate, revenue growth, profit margin and future P/E as the main factors supporting the unchanged view. What's in the News Corbion N.V. proposed a special dividend of €0.36 per share, planned for distribution in 2025.Anlatı Güncellemesi • Mar 10
CRBN: Special Dividend And Stronger Margins Will Support A More Optimistic Outlook
Analysts have trimmed their price target on Corbion from €24.60 to about €24.17, reflecting updated views on its projected revenue growth, profit margins, and future P/E assumptions. What's in the News Corbion N.V. proposed a special dividend of €0.36 per share for 2025, which may influence your expected cash returns from holding the stock (Key Developments).Anlatı Güncellemesi • Feb 24
CRBN: Higher Future P/E Assumptions Will Support A More Optimistic Outlook
Analysts have raised their price target on Corbion from about €22.73 to €24.60, citing updated assumptions on discount rates, revenue growth, profit margins, and future P/E levels. Valuation Changes Fair Value: Updated estimate increased from about €22.73 to €24.60 per share.Anlatı Güncellemesi • Feb 09
CRBN: Buyback And Higher Discount Rate Will Pressure Overvalued Shares
Analysts have kept their price target on Corbion steady at €18.60, citing only small adjustments to assumptions around the discount rate, revenue trends, profit margins and future P/E as the basis for this unchanged view. What's in the News Corbion completed a share buyback program, repurchasing 577,615 shares for €10 million, equal to 0.99% of the company.Anlatı Güncellemesi • Jan 26
CRBN: Higher Future P/E And Execution Risks Will Shape EUR 18 Outlook
Narrative Update on Corbion Analysts have raised their fair value estimate for Corbion to €18.60 from €18.00. This reflects updated views on discount rates, long term revenue trends, profit margins, and a higher future P/E assumption, alongside recent Street research where a key price target moved to €18 from €16.50.Analiz Makalesi • Jan 14
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Corbion N.V. ( AMS:CRBN ), is not the largest company out there, but it saw a double-digit share price rise of over 10...Anlatı Güncellemesi • Jan 11
CRBN: Future P/E Reset And Margin Assumptions Will Shape EUR 18 Outlook
Analysts have raised their price target for Corbion to €18 from €16.50, citing updated assumptions on revenue trends, margins and future P/E as the main factors behind the change. Analyst Commentary The revised €18 price target still comes with a Hold stance, which signals a measured view on Corbion.Anlatı Güncellemesi • Dec 26
CRBN: Higher EUR 18 Outlook Will Test Margin Delivery Amid Muted Demand
Analysts have raised their fair value estimate for Corbion to EUR 18 from EUR 14, reflecting increased confidence in the company’s profit margin outlook and a willingness to apply a higher future earnings multiple despite more muted revenue growth expectations. Analyst Commentary Bearish analysts acknowledge the higher fair value estimate but continue to highlight a cautious stance on Corbion’s near term prospects, emphasizing that the improved target largely reflects valuation mechanics rather than a fundamental re-rating of the growth outlook.Anlatı Güncellemesi • Dec 12
CRBN: Margin Improvements And Buybacks Will Support A Future Re-Rating
Analysts have lowered their fair value price target on Corbion to EUR 30.00 from EUR 31.90, citing tempered expectations for long term revenue growth and profit margins, even as some recent Street research has modestly raised nearer term share price targets. Analyst Commentary Bullish analysts highlight that the recent upward revision in near term price targets, even from a relatively low base, reflects growing confidence that Corbion can stabilize its earnings profile and execute on margin improvement initiatives.Analiz Makalesi • Nov 14
Corbion N.V. (AMS:CRBN) Shares Could Be 35% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Corbion fair value estimate is €28.50 Current share price of...Analiz Makalesi • Jun 23
Corbion N.V.'s (AMS:CRBN) Intrinsic Value Is Potentially 65% Above Its Share Price
Key Insights The projected fair value for Corbion is €30.72 based on 2 Stage Free Cash Flow to Equity Current share...Analiz Makalesi • May 07
Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely
Key Insights Corbion's Annual General Meeting to take place on 14th of May Salary of €725.0k is part of CEO Olivier...Analiz Makalesi • Apr 10
At €17.39, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?
Corbion N.V. ( AMS:CRBN ), might not be a large cap stock, but it saw significant share price movement during recent...Analiz Makalesi • Mar 26
Corbion's (AMS:CRBN) Earnings May Just Be The Starting Point
Corbion N.V.'s ( AMS:CRBN ) earnings announcement last week was disappointing for investors, despite the decent profit...
Yeni Anlatı • Mar 02
Expanding Into Natural Antioxidants And Efficiency Improvements Will Drive Future Success
Strategic initiatives and operational optimizations are expected to significantly enhance EBITDA margins and net margins.Analiz Makalesi • Feb 28
Here's What To Make Of Corbion's (AMS:CRBN) Decelerating Rates Of Return
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Analiz Makalesi • Dec 18
Risks To Shareholder Returns Are Elevated At These Prices For Corbion N.V. (AMS:CRBN)
It's not a stretch to say that Corbion N.V.'s ( AMS:CRBN ) price-to-earnings (or "P/E") ratio of 15.8x right now seems...Analiz Makalesi • Nov 18
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Corbion N.V. ( AMS:CRBN ), might not be a large cap stock, but it received a lot of attention from a substantial price...Analiz Makalesi • Oct 31
An Intrinsic Calculation For Corbion N.V. (AMS:CRBN) Suggests It's 26% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Corbion fair value estimate is €31.60 Corbion's €23.28 share...Analiz Makalesi • Sep 26
Corbion (AMS:CRBN) Takes On Some Risk With Its Use Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analiz Makalesi • Jul 18
The Price Is Right For Corbion N.V. (AMS:CRBN)
It's not a stretch to say that Corbion N.V.'s ( AMS:CRBN ) price-to-earnings (or "P/E") ratio of 16.1x right now seems...Analiz Makalesi • Jun 20
Corbion N.V. (AMS:CRBN) Shares Could Be 25% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Corbion fair value estimate is €25.18 Corbion is estimated to...Analiz Makalesi • May 08
Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely
Key Insights Corbion will host its Annual General Meeting on 15th of May Salary of €713.0k is part of CEO Olivier...Analiz Makalesi • Apr 17
Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analiz Makalesi • Jan 20
Investor Optimism Abounds Corbion N.V. (AMS:CRBN) But Growth Is Lacking
There wouldn't be many who think Corbion N.V.'s ( AMS:CRBN ) price-to-earnings (or "P/E") ratio of 14.3x is worth a...Analiz Makalesi • Dec 18
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Corbion N.V. ( AMS:CRBN ), might not be a large cap stock, but it saw a decent share price growth in the teens level on...Analiz Makalesi • Nov 04
Estimating The Fair Value Of Corbion N.V. (AMS:CRBN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Corbion fair value estimate is €15.91 Corbion's €17.30 share...Analiz Makalesi • Sep 13
Corbion (AMS:CRBN) Has A Somewhat Strained Balance Sheet
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analiz Makalesi • Aug 04
Returns On Capital Signal Tricky Times Ahead For Corbion (AMS:CRBN)
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Analiz Makalesi • Jul 14
When Should You Buy Corbion N.V. (AMS:CRBN)?
While Corbion N.V. ( AMS:CRBN ) might not be the most widely known stock at the moment, it received a lot of attention...Analiz Makalesi • Jun 04
Corbion N.V. (AMS:CRBN) Shares Could Be 22% Above Their Intrinsic Value Estimate
Key Insights The projected fair value for Corbion is €21.22 based on 2 Stage Free Cash Flow to Equity Current share...Analiz Makalesi • Apr 21
Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analiz Makalesi • Mar 10
Corbion (AMS:CRBN) Is Paying Out A Dividend Of €0.56
Corbion N.V. ( AMS:CRBN ) has announced that it will pay a dividend of €0.56 per share on the 30th of May. The dividend...Analiz Makalesi • Feb 22
Is Now An Opportune Moment To Examine Corbion N.V. (AMS:CRBN)?
Corbion N.V. ( AMS:CRBN ), is not the largest company out there, but it received a lot of attention from a substantial...Analiz Makalesi • Jan 26
Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Analiz Makalesi • Dec 20
Is Corbion (AMS:CRBN) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analiz Makalesi • Nov 24
Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)
Today we will run through one way of estimating the intrinsic value of Corbion N.V. ( AMS:CRBN ) by taking the expected...Analiz Makalesi • Nov 09
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Corbion N.V. ( AMS:CRBN ), might not be a large cap stock, but it saw a decent share price growth in the teens level on...CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Dec 31 2025 | €2m | €760k | €75m |
| Sep 30 2025 | n/a | n/a | €70m |
| Jun 30 2025 | n/a | n/a | €66m |
| Mar 31 2025 | n/a | n/a | €56m |
| Dec 31 2024 | €2m | €725k | €46m |
| Sep 30 2024 | n/a | n/a | €48m |
| Jun 30 2024 | n/a | n/a | €50m |
| Mar 31 2024 | n/a | n/a | €47m |
| Dec 31 2023 | €2m | €713k | €43m |
| Sep 30 2023 | n/a | n/a | €48m |
| Jun 30 2023 | n/a | n/a | €54m |
| Mar 31 2023 | n/a | n/a | €72m |
| Dec 31 2022 | €2m | €650k | €90m |
| Sep 30 2022 | n/a | n/a | €76m |
| Jun 30 2022 | n/a | n/a | €63m |
| Mar 31 2022 | n/a | n/a | €70m |
| Dec 31 2021 | €1m | €569k | €78m |
| Sep 30 2021 | n/a | n/a | €97m |
| Jun 30 2021 | n/a | n/a | €116m |
| Mar 31 2021 | n/a | n/a | €95m |
| Dec 31 2020 | €1m | €550k | €73m |
| Sep 30 2020 | n/a | n/a | €49m |
| Jun 30 2020 | n/a | n/a | €24m |
| Mar 31 2020 | n/a | n/a | €25m |
| Dec 31 2019 | €831k | €275k | €26m |
Tazminat ve Piyasa: Olivier 'ın toplam tazminatı ($USD 1.80M ) Dutch pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 1.66M ).
Tazminat ve Kazançlar: Olivier 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Olivier Rigaud (62 yo)
6.8yrs
Görev süresi
€1,548,000
Tazminat
Mr. Olivier Rigaud serves as Chief Executive Officer and Chairman of the Management Board at Corbion N.V. since August 8, 2019. Mr. Rigaud is Independent Director of Balchem Corporation since September 6,...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman of the Management Board & CEO | 6.8yrs | €1.55m | Veri yok | |
| CFO & Member of Management Board | 2.1yrs | €807.00k | 0.14% € 1.7m | |
| Chief Technology Officer | less than a year | Veri yok | Veri yok | |
| Head of Investor Relations | no data | Veri yok | Veri yok | |
| Head of Public Affairs & Communication | no data | Veri yok | Veri yok | |
| Chief Human Resources Officer | 2.1yrs | Veri yok | Veri yok | |
| Chief Commercial Officer | 12.4yrs | Veri yok | Veri yok | |
| Chief Integrated Supply Officer | less than a year | Veri yok | Veri yok |
2.1yrs
Ortalama Görev Süresi
54.5yo
Ortalama Yaş
Deneyimli Yönetim: CRBN 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.1 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Supervisory Board Member | less than a year | Veri yok | Veri yok | |
| Supervisory Board Member | less than a year | Veri yok | Veri yok | |
| Independent Member of the Supervisory Board | 1.1yrs | €63.00k | Veri yok | |
| Independent Chair of the Supervisory Board | 6yrs | €114.00k | Veri yok | |
| Independent Vice Chairwoman of Supervisory Board | 11.1yrs | €96.00k | Veri yok | |
| Independent Member of the Supervisory Board | 1.1yrs | €57.00k | Veri yok |
1.1yrs
Ortalama Görev Süresi
66yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: CRBN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 1.1 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/06/15 21:53 |
| Gün Sonu Hisse Fiyatı | 2026/06/15 00:00 |
| Kazançlar | 2025/12/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Corbion N.V. 13 Bu analistlerden 7, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Setu Sharda | Barclays |
| Sebastian Bray | Berenberg |
| Fintan Ryan | Berenberg |